Administrative Core
Administrative Core
批准号:
10706317
负责人:
Peter Leif Bergsagel
金额:
$12.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-09-01 至 2026-08-31
关键词:
AchievementAdvisory CommitteesAdvocateArizonaAwarenessClinicCollaborationsCommunicationCommunitiesDetectionDevelopmentEnsureFloridaFosteringFundingGoalsGrantGrowth and Development functionGuidelinesInfrastructureLeadershipMethodsMultiple MyelomaOccupational activity of managing financesPatientsPreventionProceduresReportingReproduction sporesResearchResearch ActivityResearch PersonnelResearch Project GrantsSiteStructureSystemTeleconferencesTranslational ResearchTranslationsWorkcareerdesignoperationorganizational structureprogramssystematic review
中文摘要
项目总结/摘要
马约诊所多发性骨髓瘤孢子(孢子)管理核心的总体目标是刺激
骨髓瘤的研究,并加快将发现转化为新的和更好的预防方法,
骨髓瘤的检测和治疗。行政核心一直很好地发挥着
在上一个融资期内。在下一个资助期内,基金会将继续提供
组织结构,旨在协调研究项目的活动,科学核心,
发展计划(发展研究计划,职业提升计划)。的
行政核心将负责协调SPORE委员会的职能,包括
执行委员会、外部咨询委员会和患者倡导小组。Leif Bergsagel博士
Vincent Rajkumar将担任行政核心的联合主任。伯格萨格尔和拉杰库马尔
在上一个供资期间,作为一个团队运作良好,并将继续合作,
监督SPORE活动。行政核心将:
1)为SPORE调查人员提供领导、组织支持和财务管理
2)协调马约诊所亚利桑那州、罗切斯特和佛罗里达之间的沟通和协作,
包括支持调查人员之间交流想法,设计新项目,
翻译研究和翻译研究成果的报告
3)向科学界和公众提供信息传递
4)为与外部咨询委员会的互动提供领导和组织支持,
以及对SPORE研究项目的外部和内部审查
5)提供建立和培养合作的结构,以促进和扩大
骨髓瘤研究,包括马约中心之间的相互作用
6)与SPORE患者倡导者密切合作,以便他们了解SPORE的进展情况,以及
提高他们在各级提供投入的能力
7)培养年轻的研究者
8)与NCI沟通。
英文摘要
PROJECT SUMMARY/ABSTRACT
The overall goal of the Mayo Clinic Multiple Myeloma SPORE (SPORE) Administration Core is to stimulate
research in myeloma and to expedite the translation of discoveries into new and better methods of prevention,
detection, and treatment of myeloma. The Administration Core has served well as the organizational hub of
SPORE during the prior funding period. During the next grant period, it will continue to provide an
organizational structure designed to coordinate the activities of the research projects, scientific cores, and
developmental programs (Developmental Research Program, Career Enhancement Program). The
Administration Core will be responsible for coordinating the function of the SPORE committees including the
Executive Committee, the External Advisory Committee, and the Patient Advocate Group. Drs. Leif Bergsagel
and Vincent Rajkumar will serve as Co-Directors of the Administration Core. Bergsagel and Rajkumar
functioned well as a team during the prior funding period, and will continue to work collaboratively to provide
oversight of SPORE activities. The Administration Core will:
1) Provide leadership, organizational support, and financial management for SPORE investigators
2) Coordinate communication and collaboration between Mayo Clinic Arizona, Rochester and Florida,
including support for exchange of ideas between investigators, design of new projects, conduct of
translational research, and reporting of translational research findings
3) Provide information transfer to the scientific community and the public
4) Provide leadership and organizational support for interactions with the External Advisory Committee, as
well as external and internal review for SPORE research projects
5) Provide the structure for the establishment and nurture of collaborations to facilitate and expand
myeloma research including interactions between Mayo sites
6) Work closely with SPORE patient advocates so that they are aware of the progress of the SPORE, and
facilitate their ability to provide input at all levels
7) Foster young investigator development
8) Communicate with the NCI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
preclinical optimization of BCMA directed T cell therapy
-
批准号:10802050
-
项目类别:
-
资助金额:$62.19万
-
财政年份:2023
-
负责人:Peter Leif Bergsagel
-
依托单位:
Admin Core
-
批准号:10006207
-
项目类别:
-
资助金额:$8.37万
-
财政年份:2020
-
负责人:Peter Leif Bergsagel
-
依托单位:
Admin Core
-
批准号:10494370
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Overcoming Drug Resistance in Multiple Myeloma
-
批准号:10006064
-
项目类别:
-
资助金额:$118.03万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Overcoming Drug Resistance in Multiple Myeloma
-
批准号:10414667
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Overcoming Drug Resistance in Multiple Myeloma
-
批准号:9985240
-
项目类别:
-
资助金额:$131.16万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:10488637
-
项目类别:
-
资助金额:$203.16万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Administrative Core
-
批准号:10270452
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:10706314
-
项目类别:
-
资助金额:$197.64万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mutations that Distinguish Benign from Malignant Plasma Cell Neoplasams
-
批准号:9194396
-
项目类别:
-
资助金额:$37.97万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Oncolytic Virotherapy for Multiple Myeloma using VSV
-
批准号:8930233
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:10270451
-
项目类别:
-
资助金额:$209.12万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Project 3: Early detection and prevention of MM progression
-
批准号:10270457
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Administrative Core
-
批准号:10488639
-
项目类别:
-
资助金额:$12.04万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:9331487
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Project 3: Early detection and prevention of MM progression
-
批准号:10488670
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:8250027
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:8061624
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:8462114
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:7736610
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
海外基金